Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Aktaa, S; Gale, CP; Brida, M; Giannakoulas, G; Kovacs, G; Adir, Y; Benza, RL; Böhm, M; Coats, A; D'Alto, M; Escribano-Subias, P; Ferrari, P; Galiè, N; Gibbs, JSR; Gin-Sing, W; Hoeper, MM; Humbert, M; Lang, IM; Maron, BA; Meszaros, G; Vonk, Noordegraaf, A; Price, LC; Pepke-Zaba, J; Rådegran, G; Reis, A; Sitbon, O; Torbicki, A; Ulrich, S; Rosenkranz, S; Delcroix, M.
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2023; 25(4):469-477 Doi: 10.1002/ejhf.2830
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Kovacs Gabor

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

AIMS: To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults with pulmonary arterial hypertension (PAH). METHODS AND RESULTS: We followed the European Society of Cardiology (ESC) methodology for the development of QIs. This included (i) the identification of key domains of care for the management of PAH, (ii) the proposal of candidate QIs following systematic review of the literature, and (iii) the selection of a set of QIs using a modified Delphi method. The process was undertaken in parallel with the writing of the 2022 ESC/European Respiratory Society (ERS) guidelines for the diagnosis and treatment of pulmonary hypertension and involved the Task Force chairs, experts in PAH, Heart Failure Association (HFA) members and patient representatives. We identified five domains of care for patients with PAH: structural framework, diagnosis and risk stratification, initial treatment, follow-up, and outcomes. In total, 23 main and one secondary QIs for PAH were selected. CONCLUSION: This document presents the ESC QIs for PAH, describes their development process and offers scientific rationale for their selection. The indicators may be used to quantify and improve adherence to guideline-recommended clinical practice and improve patient outcomes.

Find related publications in this database (using NLM MeSH Indexing)

Humans - administration & dosage

Adult - administration & dosage

Pulmonary Arterial Hypertension - diagnosis

Quality Indicators, Health Care - administration & dosage

Heart Failure - complications, diagnosis, therapy

Hypertension, Pulmonary - diagnosis, therapy

Cardiology - administration & dosage

Find related publications in this database (Keywords)

Pulmonary arterial hypertension

Quality indicators

Treatment

Accountability

Clinical practice guidelines

Outcomes

© Med Uni Graz • Imprint